"Dr. Anthony Traboulsee writes an opinion piece regarding his latest UBC research interim findings. He steadfastly maintains his findings can be conclusive after only 48 weeks and before the second phase is completed and factored into the analysis. Furthermore , he still fails to acknowledge any limitations of his study. All researchers know a fundamental part of all research reporting is acknowledging where your study falls short in terms of methodology, execution or bias. By not doing so, and by continuing to blitz the media, Dr. Traboulsee exhibits a bias unbecoming of a research scientist. Normally, researchers stay out of the media and leave the debate on their findings to other researchers in the academic realm. Dr. Traboulsee not only courted the media with media releases, interviews, and this opinion piece, but is now attempting to shut down any further scientific inquiry into venous abnormalities and their treatment in relation to the disease course of multiple sclerosis..."

Much anticipated initial results of the Canadian chronic cerebrospinal venous insufficiency (CCSVI) clinical trial for multiple sclerosis (MS) were announced on March 8.